Search Results

The Laurie K. Lacob Pavilion at the Stanford Medicine Cancer Center opened July 17. The state-of-the-art facility, for transplant and cellular therapies, is a light-filled space for healing.

Stanford Medicine researchers find that using in vitro fertilization with testing embryos for inherited diseases would significantly reduce costs.

An international effort led by a Stanford Medicine researcher finds more than 50 genes linked to glioma — a rare brain cancer. Although most gliomas are sporadic, a minority are inherited.

Fat from olive oil and nuts boosts the numbers of two key cellular structures and protects membranes from damage, lengthening the lives of laboratory worms, Stanford Medicine-led study finds.

Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.

Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.

Telomeres shorten in heart muscle cells from people with Duchenne muscular dystrophy. A Stanford Medicine study finds blocking this process improves the health of these cells grown in a dish.

The California Institute for Regenerative Medicine has funded Stanford Medicine projects to improve kidney transplantation and advance treatment for a rare genetic disease in children.

Old muscle stem cells express high levels of the cancer-associated molecule CD47. Blocking a pathway mediated by CD47 restored strength to old mice in a Stanford Medicine study.

A technique developed at Stanford Medicine allows mice with diabetes to accept unmatched islet cells and durably restores blood sugar control without immunosuppression or graft-versus-host disease.